Get started
Author

Jingping Shao

Observed name: JING-PING SHAO
Observed institution: Zhejiang Pharmaceutical College
ORCID: 0000-0001-8642-4194
Observed ORCID: 0000-0001-8642-4194
OpenAlex ID: A5089394714
IL-33-induced JNK pathway activation confers gastric cancer chemotherapy resistance
2015 · XIAO-LEI YE, YA-RONG ZHAO, et al. · Oncology Reports · 60
PDF
Danshensu derivative ADTM ameliorates CCl4‑induced acute liver injury in mice through inhibiting oxidative stress and apoptosis
2021 · Shu Jia, Qi Chen, et al. · Pathology - Research and Practice · 19
Bicyclol attenuates high fat diet-induced non-alcoholic fatty liver disease/non-alcoholic steatohepatitis through modulating multiple pathways in mice
2023 · Jingyi Wu, Shu Jia, et al. · Frontiers in Pharmacology · 11
PDF
Bicyclol alleviates high-fat diet-induced hepatic ER stress- and autophagy-associated non-alcoholic fatty liver disease/non-alcoholic steatohepatitis in mice
2022 · Shu Jia, Lianyu Jin, et al. · Drug Development and Industrial Pharmacy · 6
Mechanistic Evaluation of Roxadustat for Pulmonary Fibrosis: Integrating Network Pharmacology, Transcriptomics, and Experimental Validation
2026 · Congcong Zhang, Xinyue Huang, et al. · Pharmaceuticals · 1
PDF
Effects of bicyclol on hepatic sinusoidal obstruction syndrome induced by Gynura segetum
2022 · Jianzuo Yao, Jingyi Wu, et al. · Journal of Clinical Laboratory Analysis · 1
PDF
Physiologically based pharmacokinetic modelling and dose optimization of tedizolid in paediatric patients
2026 · Xueyong Li, Yu Cheng, et al. · British Journal of Clinical Pharmacology
PDF
Works count: 7
Citation count: 98
H-index: 4
I10-index: 3
Year
Topic
Type